Verum Partners LLC Sells 58 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Verum Partners LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,512 shares of the healthcare conglomerate’s stock after selling 58 shares during the period. Verum Partners LLC’s holdings in UnitedHealth Group were worth $792,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Geode Capital Management LLC lifted its holdings in UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after buying an additional 319,515 shares during the period. Capital International Investors lifted its stake in shares of UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the last quarter. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter valued at about $6,375,744,000. Northern Trust Corp lifted its position in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. grew its position in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after buying an additional 861,854 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $303.24 on Friday. The company’s fifty day moving average price is $409.03 and its 200 day moving average price is $484.21. The company has a market capitalization of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the company posted $6.91 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. KeyCorp lowered their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Robert W. Baird lowered their price target on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Finally, Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $428.43.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of the firm’s stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.